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Abstract
Background: Bone marrow lesions (BMLs), common osteoarthritis-related magnetic resonance imaging findings,
are associated with osteoarthritis progression and pain. However, there are no articles describing the use of 3-
dimensional quantitative assessments to explore the longitudinal relationship between BMLs and hyaline cartilage
loss. The purpose of this study was to assess the cross-sectional and longitudinal descriptive characteristics of BMLs
with a simple measurement of approximate BML volume, and describe the cross-sectional and longitudinal
relationships between BML size and the extent of hyaline cartilage damage.
Methods: 107 participants with baseline and 24-month follow-up magnetic resonance images from a clinical trial
were included with symptomatic knee osteoarthritis. An ‘index’ compartment was identified for each knee defined
as the tibiofemoral compartment with greater disease severity. Subsequently, each knee was evaluated in four
regions: index femur, index tibia, non-index femur, and non-index tibia. Approximate BML volume, the product of
three linear measurements, was calculated for each BML within a region. Cartilage parameters in the index tibia
and femur were measured based on manual segmentation.
Results: BML volume changes by region were: index femur (median [95% confidence interval of the median]) 0.1
cm
3 (-0.5 to 0.9 cm
3), index tibia 0.5 cm
3 (-0.3 to 1.7 cm
3), non-index femur 0.4 cm
3 (-0.2 to 1.6 cm
3), and non-
index tibia 0.2 cm
3 (-0.1 to 1.2 cm
3). Among 44 knees with full thickness cartilage loss, baseline tibia BML volume
correlated with baseline tibia full thickness cartilage lesion area (r = 0.63, p< 0.002) and baseline femur BML volume
with longitudinal change in femoral full thickness cartilage lesion area (r = 0.48 p< 0.002).
Conclusions: Many regions had no or small longitudinal changes in approximate BML volume but some knees
experienced large changes. Baseline BML size was associated to longitudinal changes in area of full thickness
cartilage loss.
Background
Knee osteoarthritis (OA) is the most common form of
arthritis, accounting for substantial disability in the gen-
eral population [1]. However, there are many gaps in
our knowledge regarding the pathophysiology of this
disease. Recent evidence suggests that peri-articular
bone changes are integral to knee OA pathophysiology
and may be important for identifying new OA treat-
ments [2-13].
Bone marrow lesions (BMLs), common OA-related
magnetic resonance (MR) imaging findings (Figure 1),
are associated with OA progression and pain [2-13].
BMLs have been implicated with increased odds of hya-
line cartilage damage and subchondral bone attrition
[2-5,7-9,12]. To date, no one has published articles
describing the use of 3-dimensional quantitative assess-
ments to explore the longitudinal relationship between
BMLs and hyaline cartilage. * Correspondence: jdriban@tuftsmedicalcenter.org
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of measuring approximate BML volume that uses the
product of three linear measurements across images.
This method was selected because it does not require
proprietary software, requires less time to measure, and
provides a continuous measure of approximate BML
size. In this manuscript we 1) report cross-sectional and
longitudinal descriptive BML characteristics with this
new method, and 2) describe the cross-sectional and
longitudinal relationships between approximate BML
volume and the extent of hyaline cartilage damage using
quantitative 3-dimensional measurements.
Methods
Study sample
This study was a secondary analysis of a recently com-
pleted randomized, placebo-controlled, clinical trial of
vitamin D among participants with knee OA (n =1 4 6 ) .
All participants with both baseline and 24-month fol-
low-up images were included in this study (n = 107 par-
ticipants). All participants were required to have knee
OA as defined by the American College of Rheumatol-
ogy [14] and be over 45 years of age. Additional inclu-
sion criteria were that participants had to have chronic
knee discomfort (knee discomfort on most days for at
least one month in past 12 months), Western Ontario
and McMaster Universities Osteoarthritis Index
(WOMAC) pain subscale ≥ 1, tibiofemoral OA on pos-
terior-anterior weight-bearing semi-flexed knee radio-
graphs (equivalent to Kellgren and Lawrence [KL] grade
≥ 2), and clinical examination confirming knee pain or
discomfort referable to the knee joint. To compare the
cross-sectional and longitudinal relationships between
regional approximate BML volume and the extent of
hyaline cartilage damage a sample consisting of 44
knees was selected that only included knees with full
thickness cartilage lesions at baseline. This sample is
smaller than the full sample because these analyses were
restricted to knees with full thickness cartilage lesions to
avoid statistical issues associated with more than half of
the knees having no areas of full thickness cartilage loss.
The Institutional Review Board of Tufts Medical Center
approved the study and informed consent was obtained
from all participants prior to inclusion.
Knee selection
One knee was identified as the study knee for each par-
ticipant. If both knees were eligible, then the knee with
a greater WOMAC pain subscale score was selected. If
both knees had equivalent WOMAC pain subscale
scores, the knee with a greater KL grade was chosen.
Finally, if WOMAC pain subscale scores and KL grades
were equivalent for both knees, the study knee was ran-
domly selected.
Index compartment selection
Within each knee, a rheumatologist (TEM) defined an
index compartment (medial or lateral tibiofemoral) as
the compartment with greater pathology based on radio-
graphs. If the medial and lateral tibiofemoral compart-
ments were comparable then MR images were assessed
for cartilage damage, bone marrow lesions, and meniscal
Figure 1 Bone marrow lesion measurements within the lateral tibia. a. In the sagittal image the superior-inferior dimension (0.9 mm) and
anterior-posterior dimension (0.7 mm) are measured. b. In the coronal image the medial-lateral dimension is measured (1.1 mm). The image
contrast is optimized for measuring bone marrow lesions based on the measurement protocol (not for viewing other anatomical structures).
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verified the index compartment by evaluating MR
images. If disagreement arose a consensus decision was
achieved.
MR image acquisition
MR images of the study knees were obtained at baseline
and at 2 years follow-up on a Siemens Magnetom
Avanto 1.5T (Malvern, PA). The sequences of relevance
for BML assessment were sagittal and coronal inter-
mediate-weighted (IW) fat-suppressed (FS) images with
time to recovery (TR) of 2950 ms, time to echo (TE) of
31 ms, slice thickness of 3 mm, space thickness of 0.5
mm, and field of view (FOV) of 140 mm. The sequences
of relevance for cartilage volume assessment were 3-
dimensional sagittal water excitation dual echo steady
state (DESS WE) images with time to recovery (TR) of
18.2 ms, time to echo (TE) of 5.28 ms, slice thickness of
1.3 mm, and field of view (FOV) of 140 mm.
BML assessment
BMLs were evaluated on IW FS MR images at baseline
and 2-years. We defined BMLs as ill-defined areas of
high-signal intensity located within 1.0 cm of articular
cartilage and present on either ≥ 2s a g i t t a li m a g e sa n d /
or ≥ 2 coronal images and classified them within 4
regions: index femoral region (representing the femoral
region of the index compartment), non-index femoral
region (representing the femoral region of the opposite
compartment), index tibial region, and non-index tibial
region. Prior to measuring BML size, image brightness
and contrast were adjusted until normal bone signal
appeared black and homogenous. Adjustments of image
contrast and brightness, as well as BML identification,
were conducted on paired images (baseline and 24
months). One reader (JD) measured the maximal ante-
rior-posterior (AP), medial-lateral (ML), and superior-
inferior dimension of each BML using the linear mea-
surement tool in eFilm Workstation 3.01 (Merge
Healthcare, Milwaukee, WI; Figure 1). AP and superior-
inferior dimensions were measured on sagittal images
and the ML dimension was determined on coronal
images. For each lesion, the linear measurement tool
was used to mark the BML edges that defined the great-
est diameter for each dimension (e.g. AP, ML) on the
sagittal and coronal images with the largest BML cross-
section. The line measurements were then copied to all
images within the image set and the reader reviewed the
adjacent images to determine if the BML extended
beyond the measurement lines in any of the other slices.
If the BML extended beyond the line then the measure-
ment line was lengthened to represent the maximum
width of the BML across images.
We took the product of the three linear measurements
to represent the approximate volume of each BML.
When multiple BMLs were present in a region (e.g.
index femur) their approximate volumes were summed
to calculate regional approximate volume. Regional
approximate BML volume changes were defined as pro-
gression if the volume increased and regression if the
volume decreased. We also measured peak signal inten-
sity in each BML on coronal images. Peak signal inten-
sity was normalized to normal bone marrow signal to
correct for variations in signal intensity that occurs
across MR image acquisitions. Normal bone marrow sig-
nal intensity was collected from the posterior non-index
femur because this region consistently had no BMLs.
When multiple BMLs were present, the BML with
greatest signal intensity defined the regional peak signal
intensity. Intra-tester reliability (intraclass correlations
[ICC 3,1 model])[15] for BML measurements ranged
from 0.87 to 0.98 for BML linear measurements; 0.96
and 0.90 for volume and volume change; 0.88 for peak
signal intensity. The manually-measured approximate
BML volumes were correlated to segmentation BML
volumes performed by an independent rater (JP; ICC
[2,1] = 0.81, n = 17 BMLs). Furthermore, a Bland-Alt-
man analysis indicated the 95% limit of agreement
between manual and segmented BML size ranged from
-2.8 to 1.3 cm
3. Sixteen of the 17 manually-measured
approximate BML volumes were in agreement with the
segmented BML volume. Manual measurements were
always greater than the segmented BML volumes (ran-
ged from -3.8 to 0.0 cm
3).
Cartilage assessment
Cartilage parameters were evaluated on sagittal DESS
MR images at baseline and 24 months. Using Analyze
8.1
© (Mayo Clinic, Rochester, MN), one investigator
(JYL), unblinded to the image acquisition order, regis-
tered the baseline and 24 month MR images and then
performed paired manual segmentation of the index-
compartment tibia and femur cartilage (Figure 2). Per-
ipheral osteophytes were excluded in image segmenta-
tion. After completion of the manual segmentation
cartilage volume (mm
3) was calculated using Analyze
(intra-tester ICC > 0.99).
To assess areas of full-thickness cartilage lesions, a
second investigator (JBD) used Analyze 8.1
© to place a
line in areas of full thickness cartilage lesions (Figure 2).
In full thickness cartilage lesions with a central osteo-
phyte the segmentation line was placed through the
base of the osteophyte [16]. A MatLab (The MathWork,
Natick, MA) custom program (written by EM) then ana-
lyzed these images and calculated mean cartilage thick-
ness (with regions of full thickness cartilage lesions
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cartilage lesions.
The custom MatLab program used the pixels identi-
fied as cartilage in each image. Binary morphological
processing methods [17,18] were employed to determine
the mean cartilage thickness. For each image slice the
thickness of each connected component (CC) of the car-
tilage was computed as the mean distance from each
pixel on the boundary of that CC from the morphologi-
cal skeleton (a generalization of the centerline to arbi-
trary shapes) of that CC. This mean cartilage thickness
was computed as twice the total distance to the skeleton
of all points along the perimeter divided by the number
of points times the linear size of each voxel.
To determine the length of full thickness cartilage
lesions in each MR image slice the following process
was undertaken. First, the morphological skeletons were
computed for each pair of connected cartilage segments
that was separated by a full thickness cartilage lesion. A
second order polynomial was fit to the points from both
morphological skeletons resulting in a curve that
“spanned” the full thickness cartilage lesion between the
two pieces of cartilage. The portion of this curve not
overlapping the two cartilage pieces was taken to be the
length of the full thickness cartilage lesion. To deter-
mine the mean cartilage thickness including the full
thickness cartilage lesion, we estimated the number of
pixels that comprise the full thickness cartilage lesion as
the product of the full thickness cartilage lesion length
and the density of pixels (pixels per unit length) as com-
puted from the two bordering cartilage segments. The
mean cartilage thickness including the full thickness car-
tilage lesion in each slice was then computed as pre-
viously described, but the number of points in the
denominator was the sum of the number of pixels asso-
ciated with both the full thickness cartilage lesion and
cartilage segments. The mean cartilage thickness (with
regions of full thickness cartilage lesions represented as
0 mm) was averaged across slices.
Finally, the area of full thickness cartilage lesion was
computed as the ratio of the area of the full thickness
cartilage lesion to the area of the full thickness cartilage
lesion plus the surface area of the cartilage pieces (total
area of subchondral bone) where the latter was calcu-
lated as the curve length of the second order polynomial
that did intersect the two pieces of cartilage [17,18].
Statistical analyses
Descriptive data were calculated for the study sample.
Change in approximate BML volume was classified as
regression (getting smaller), progression (getting larger),
or no change in size relative to measurement error (test,
retest). Longitudinal BML measurement error was calcu-
lated with the reliability data set (described above) by
calculating the difference between the first approximate
B M Lv o l u m ec h a n g ea n dt h er e t e s ta p p r o x i m a t eB M L
volume change (Differences in approximate BML
volume change = [Follow-up1 - Baseline1] - [Follow-up2
- Baseline2]). Smallest detectable differences were origin-
ally calculated based on two standard deviations of the
differences in approximate BML volume change (i.e.,
95% confidence interval [95% CI] of the mean), however
t h ed a t aw e r en o tn o r m a l l yd i s t r i b u t e da n dt h es a m p l e
size was small (n = 16 BMLs, mean = 1.86 cm
3, median
=0 . 4c m
3, standard deviation = 5.99 cm
3). Therefore,
the smallest detectable difference was derived from the
95% CI of the median (median = 0.4 cm
3; 95% CI = -0.1
to 3.2 cm
3). To be conservative, we chose the larger
endpoint of the 95% CI of the median. BML regression
was defined as an approximate BML change less than
-3.2 cm
3 over 2 years and BML progression was defined
as an approximate BML change greater than 3.2 cm
3
over 2 years (changes between -3.2 cm
3 and 3.2 cm
3
were classified as no change). To further explore this
definition of change we evaluated a boot-strapping
resampling method (1000 resamples). This method and
the 95% CI of the median resulted in a similar distribu-
tion for classifying BMLs as regression, no change, and
progression.
Regional BML cross-sectional and longitudinal
descriptive characteristics were limited to participants
with BMLs present in the specific region (e.g. index
femur). We used Spearman correlations to evaluate the
Figure 2 Cartilage segmentation (green and red outlines) with
lines (purple and blue) in areas of a full thickness cartilage
lesion.
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longitudinal BML volume as well as regional approxi-
mate BML volume and extent of cartilage damage.
T h e s ec o r r e l a t i o n sw e r el i m i t e dt oas a m p l eo fk n e e s
with full thickness cartilage lesions at baseline (see the
Study Sample section for justification). Fisher’szt r a n s -
formations were performed to determine 95% CI for
correlation coefficients. To assess the external validity of
the correlations between approximate BML volume and
extent of cartilage damage, Spearman correlations were
analyzed, using the entire cohort (n = 107), to evaluate
the intra-regional associations between regional approxi-
mate BML volume, cartilage volume, and cartilage thick-
ness. Differences in correlation coefficients between the
entire cohort and subset with full thickness cartilage
lesions were defined by coefficients being within the
95% confidence intervals of the correlation coefficient
that it was being compared. Bonferroni corrections were
used to correct for the 24 Spearman correlations that
evaluated the hypotheses that approximate BML
volumes were associated with cartilage damage (adjusted
p value for significance was p < 0.002). Significant uni-
variate correlations were explored with follow-up step-
wise multiple linear regression models to determine if
potential covariates (i.e., age, sex, body mass index,
intervention group) influenced the associations.
Within the index compartment structural changes in
the femur or tibia may alter the loading throughout the
compartment. Therefore, exploratory Spearman correla-
tions evaluated the inter-regional relationships within
the index compartment between regional approximate
BML volume and extent of cartilage damage. We used
SAS 9.2 (SAS Institute, Cary, NC) to calculate regional
approximate BML volumes, derive median and 95% CI
for the median as well as perform all statistical analyses.
Results
Descriptive characteristics of regional approximate BML
volume and signal intensity
From the original trial, 107 participants were included in
the analyses with a mean age of 63 ± 9 years, mean
body mass index of 29.8 ± 5.4 kg/m
2, 64% female; and
52% KL grade 2 (56 knees),30% KL grade 3 (32 knees),
and 18% KL 4 grade (19 knees). In this sample 101
(94%) knees had ≥ 1 BML (range 1 to 7) for a total of
240 BMLs. Furthermore, 45 (19%) BMLs regressed (got
smaller), 61 (25%) BMLs progressed (got larger), and
134 (56%) did not change over two years. Table 1 pro-
vides regional baseline approximate BML volumes.
While most regions demonstrated no or small regional
approximate BML volume changes over 2 years, some
underwent large changes (Figure 3, Table 1). Longitudi-
nal changes in regional approximate BML volume were
not related to baseline approximate BML volumes
(Table 1; see scatter plots in Additional File 1).
Relationships between approximate BML volume and
cartilage parameters within index compartments
To compare the cross-sectional and longitudinal relation-
ships between regional approximate BML volume and
the extent of hyaline cartilage damage, a sample consist-
ing of 44 knees was selected (65 ± 9 years of age (mean ±
standard deviation), 52% female, and body mass index of
29.8 ± 5.8 kg/m
2). Among index femurs, 91% had a full
thickness cartilage lesion at baseline (baseline cartilage
lesion = 12.1 ± 10.3% of subchondral bone; 2 knees
developed a full thickness cartilage lesion when none was
present at baseline; change = 1.5 ± 1.8% of subchondral
bone) and 91% had baseline BMLs (baseline BML size =
15.3 ± 16.0 cm
3; 1 knee developed a BML when none
was present at baseline; 4 knees had a BML at baseline
that was absent at follow-up; change = 1.6 ± 12.4 cm
3).
Among index tibiae, 66% had a full thickness cartilage
lesion at baseline (baseline cartilage lesion = 24.8 ± 17.8%
of subchondral bone; 3 knees developed a full thickness
cartilage lesion when none was present at baseline;
change = 3.0 ± 4.7% of subchondral bone) and 84% had
baseline BMLs (baseline BML size = 30.7 ± 31.5 cm
3;2
knees developed a BML when none was present at base-
line; change = 3.9 ± 14.8 cm
3).
Table 2 describes the intra-regional correlations, in
the index compartment, between cartilage and regional
approximate BML volume (see scatter plots in Addi-
tional File 1). After Bonferroni adjustments for multiple
testing only two statistically significant correlations were
present between regional approximate BML volume and
cartilage parameters: baseline tibia BML volume to base-
line tibia full thickness cartilage lesion area and baseline
Table 1 Median (95% CI) Baseline and Longitudinal Changes in Approximate BML Volume
Region Baseline BML Volume (cm
3) BML Volume Change (cm
3) Spearman Correlation (95% CI):
Baseline to Longitudinal Change
Index Femur (n = 76) 4.2 (2.5 to 11.5) 0.1 (-0.5 to 0.9) -0.20 (-0.41 to 0.02)
Index Tibia (n = 76) 8.8 (3.9 to 14.3) 0.5 (-0.3 to 1.7) -0.14 (-0.35 to 0.09)
Non-index Femur (n = 33) 2.6 (1.6 to 8.2) 0.4 (-0.2 to 1.6) -0.06 (-0.40 to 0.29)
Non-index Tibia (n = 30) 1.1 (0.6 to 3.9) 0.2 (-0.1 to 1.2) -0.27 (-0.57 to 0.10)
No Spearman correlation coefficients were statistically significant. 95% CI = 95% confidence interval of the median or 95% confidence interval of the Spearman
Correlation. See Additional File 1 for scatter plots of the analyzed correlations.
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cartilage lesion area. There were no other statistically
significant correlations between cartilage parameters
(baseline or change) and BML volume change. To assess
the external validity of these findings, approximate BML
volume and extent of cartilage damage correlations
between approximate BML volume, cartilage volume,
and cartilage thickness were evaluated and determined
to be similar between the subset (n =4 4 )a n de n t i r e
cohort (n = 107; see table in Additional File 2). Based
on stepwise multiple linear regressions age, sex, body
mass index, or intervention group did not influence sig-
nificant univariate associations.
Exploratory correlations between index-compartment
regions were examined: index-femoral baseline BML with
index-tibial baseline full thickness cartilage lesion area (r
=0 . 4 0 ,p =0 . 0 1 ;n = 40), index-femoral baseline BML
with index-tibial full thickness cartilage lesion area
change (r = 0.39, p = 0.01; n = 40), index-tibial baseline
BML with index-femoral baseline full thickness cartilage
lesion area (r = 0.55, p <0 . 0 0 1 ,n = 37), index-tibial BML
change with index-femoral baseline cartilage volume (r =
-0.33, p = 0.04, n = 39), and index-tibial BML change
with index-femoral baseline cartilage thickness (r = -0.38,
p = 0.02, n = 39). No other statistically significant corre-
lations were detected across regions of the index.
Figure 3 Histograms of bone marrow lesion (BML) size change among regions with BMLs. Each bar represents a range of 2.5 cm
3.
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This study used a simple and novel method of measur-
ing approximate BML volume that can be easily
employed by researchers and clinicians. The technique
demonstrated that many knee regions experienced small
longitudinal changes in regional approximate BML
volume over 2 years (± 2.5 cm
3) but some knees experi-
enced large longitudinal changes. In agreement with
previous findings, baseline regional approximate BML
volume and hyaline cartilage full-thickness lesion area
(baseline and longitudinal change) were associated
[2,4,5,7,8,12,19-28]. The new BML measurement techni-
que is sensitive to small changes in BML size over 2
years and, in agreement with previous literature, posi-
tively associated with increased cartilage damage.
To our knowledge, this is the first full-length publica-
tion reporting the longitudinal relationship between 3-
dimensional quantitative measurements of BML size and
hyaline cartilage among knees with OA. Several methods
have been deployed to quantify BML size but they have
various limitations. One method uses manual segmenta-
tion of all MR image slices that display a BML. This
method is time consuming and usually requires proprie-
tary software [29-36]. Therefore, a segmentation techni-
que is difficult to deploy researchers working with large
cohorts. A less labor-intensive method that has been
used is to take the measurement of the greatest dia-
meter of a lesion. One potential downside to this
approach is that it does not account for the three-
dimensional nature of these lesions [7]. An alternative
method that is not very labor intensive approximates
BML volume with three linear measurements; specifi-
cally, the coronal and sagittal images with the largest
area of signal abnormality are identified and the largest
three dimensions from these two images [37,38]. While
this appears to be a good compromise between function
and practicality, this method does not take into account
for the possibility that the greatest width of a BML may
change as you view adjacent coronal or sagittal images
(Figure 4). By measuring the greatest diameter across
images the current technique attempts to account for
the potential limitations that a single image may not
adequately describe the 3-dimensional size of an irregu-
larly shaped BML.
Baseline regional approximate BML volume is posi-
tively associated with baseline and longitudinal changes
in full thickness cartilage lesion area. A positive correla-
tion between semiquantitative assessments of BML size
and cartilage damage have been demonstrated in cross-
sectional [4,20-24] and longitudinal studies
[2,4,5,8,19,24,25]. Previous reports regarding the within-
region association between BML size and cartilage
volume, the most common quantitative measure of hya-
line cartilage, are conflicting with some showing statisti-
cally significant associations [7,12,21,24,26-28] and
others showing non-significant associations
[2,7,20,21,25,27]. The current correlations concur with
previously reported associations between longitudinal
change of BML size (greatest diameter) and cartilage
volume (r = -0.03 to -0.40)[7]. Furthermore, one article,
which distinguished between full thickness cartilage
lesions and normal or partial thickness lesions, noted
that only 7% of knees (11/149 knees) with normal carti-
lage or partial thickness defect had a BML greater than
1 cm in size while 33% of knees (16/48 knees) with a
full thickness defect had a BML greater than 1 cm [10].
T h e s ed a t as u p p o r tt h ec u r r e n tf i n d i n g st h a tB M Ls i z e
may have a strong association with full thickness carti-
lage lesion area.
Baseline regional approximate BML volume was statis-
tically associated with baseline and longitudinal changes
in full thickness cartilage lesion area but not cartilage
thickness or volume. The similar findings between carti-
lage thickness and volume are not unexpected since the
Table 2 Within-Region Spearman Coefficients (95% Confidence Intervals) Among Baseline BML and Cartilage
Parameters in the Index Compartment
Femur BML Volume:
Baseline
(n = 40)
Tibia BML Volume:
Baseline
(n = 37)
Femur BML Volume:
Change
(n = 41)
Tibia BML Volume:
Change
(n = 39)
Baseline
Cartilage Volume -0.06 (-0.37, 0.25) -0.31 (-0.57, 0.02) -0.06 (-0.37, 0.25) -0.08 (-0.39, 0.24)
Cartilage Thickness 0.02 (-0.30, 0.33) -0.37 (-0.62, -0.05) -0.12 (-0.42, 0.19) -0.02 (-0.33, 0.30)
Full Thickness Cartilage Lesion
Area
0.33 (0.02, 0.58) 0.63 (0.38, 0.79)* -0.06 (-0.36, 0.26) -0.03 (-0.34, 0.29)
2-year Longitudinal Change
Cartilage Volume 0.03 (-0.29, 0.34) 0.16 (-0.18, 0.46) -0.10 (-0.39, 0.22) 0.32 (0.00, 0.58)
Cartilage Thickness -0.11 (-0.41, 0.21) -0.13 (-0.43, 0.21) -0.15 (-0.43, 0.17) 0.04 (-0.28, 0.35)
Full Thickness Cartilage Lesion
Area
0.48 (0.20, 0.69)* 0.43 (0.12, 0.66) 0.08 (-0.23, 0.38) -0.18 (-0.47, 0.14)
* statistically significant finding after Bonferroni corrections (24 multiple comparisons; p < .002; see Additional File 1 for scatter plots).
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lage thickness determines cartilage volume). Although
the design of this study did not allow us to determine
why regional BML volumes had stronger correlations
with full thickness cartilage lesion area compared to car-
tilage volume or thickness, we speculate that BMLs are
an early and sensitive biomarker of localized degenera-
tion in response to altered loading. Furthermore, BMLs
may also contribute to localized cartilage loss leading to
full thickness cartilage lesions. A second hypothesis is
that BMLs have a localized influence on cartilage loss
and full thickness cartilage lesion area is a more loca-
lized measure of hyaline cartilage loss than the other
two measures. These hypotheses are supported by the
associations between baseline BML size and longitudinal
changes in full thickness cartilage lesion area. A third
hypothesis is that the association between BML size and
c a r t i l a g ev o l u m ea n dt h i c kness is impeded because OA
progression defined by cartilage thickness and volume is
not always linear. Some patients experience increased
cartilage thickness with KL grade 2 (23% of knees) and
KL grade 3 (18%) while the majority lose cartilage thick-
ness and volume [39]. In contrast, full thickness carti-
lage lesion area progresses in a linear pattern, which
supports its higher correlations with BML size.
Exploratory analyses across regions demonstrated statis-
tically significant associations including relations between
baseline cartilage and regional approximate BML volume
change. When assessing predictors of longitudinal carti-
lage loss or BML volume change it is important to con-
sider other regions. Altered structure in one region of the
index compartment is likely to alter the loading in both
index regions. Inter-regional associations between BML
and cartilage parameters warrant its own research. Few
studies have evaluated inter-region relationships between
BMLs and cartilage parameters but there is previous
research to support these relationships. Statistically signifi-
cant inter-regional correlations between baseline BML size
(semi-quantitative) and cartilage volume change have been
reported [28]. When accounting for variables that predict
disease progression (e.g. cartilage loss, BML progression) it
may be important to consider the influence of other
regions throughout the joint.
Our study showed that small changes in BML size
were common but that there is a large variation among
knees with OA. This corroborates findings from other
investigators who also found that among OA knees with
BMLs, there was a large variability of longitudinal BML
size change [7,36]. In a small sample (n = 14), investiga-
tors using semi-automated BML segmentation showed
that 43% increased BML volume (change greater than
5%), 36% decreased BML volume, and 21% did not
change (± 5% change)[36]. Small longitudinal changes
Figure 4 Measurements of approximate BML volume based on
only the coronal and sagittal images with the largest area of
signal abnormality may misrepresent the greatest diameter of
a BML. Image 10, image with the largest BML area, would
traditionally be measured to approximate BML volume and result in
an anterior-posterior diameter of 1.2 cm but with the newer
technique, measuring across images (including images 9 and 11),
the anterior-posterior diameter is 1.5 cm. The white circles indicate
areas of increased signal intensity beyond the dimensions indicated
on image 10. The image contrast is optimized for measuring bone
marrow lesions based on the measurement protocol (not for
viewing other anatomical structures).
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ments of maximum BML diameter (i.e. coefficient of
variation [CV] = 719%, 4,360%)[7].
While the findings of the current study are interesting,
there are several limitations. Approximate BML volume
over-estimates the true BML volume but may be
strongly correlated to the true BML volume. Further-
more, the method may not detect subtle changes within
the baseline approximate volume.
Our data support the construct validity of the new
methodology. This technique is intended to be a simple
and efficient method of measuring 3-dimensional BML
size that can be done with standard MR imaging view-
ing software. Future research should determine the rela-
tionship between true BML volume determined through
BML segmentation and approximate BML volume using
this technique.
Conclusions
In summary, this study demonstrates a method of
approximating BML volume that can be readily
adopted by clinicians and researchers. The measure-
ments detected longitudinal changes during a two-year
clinical trial. Furthermore, baseline BML size was asso-
ciated to the longitudinal changes in full thickness car-
tilage lesion area. More research is warranted to
investigate the longitudinal relationship between quan-
titative measures of tissue degeneration associated with
OA.
Additional material
Additional File 1: Intra-regional Scatter Plots. Scatter plots for
correlations presented in Table 1 and Table 2 are provided.
Additional File 2: Additional Table. Within-Region Spearman
Coefficients (95% Confidence Intervals) Among Baseline BML and
Cartilage Parameters in the Index Compartment. This table
demonstrates the correlations between approximate BML volume,
cartilage volume, and cartilage thickness among the entire study cohort
(n = 107). These correlations were evaluated and determined to be
similar between the primary subset (n = 44; Table 2) and entire cohort (n
= 107).
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